share_log

6-K: Blenrep Combination Reduced the Risk of Disease Progression or Death by Nearly 50% Versus Standard of Care Combination in Relapsed/Refractory Multiple Myeloma

6-K: Blenrep Combination Reduced the Risk of Disease Progression or Death by Nearly 50% Versus Standard of Care Combination in Relapsed/Refractory Multiple Myeloma

與標準護理組合相比,Blenrep組合可將復發/難治性多發性骨髓瘤的疾病進展或死亡風險降低近50%
美股sec公告 ·  06/03 06:15
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息